KNEE SURGERIES AND ARTHROPLASTY PAIN MANAGEMENT THERAPEUTICS MARKET ANALYSIS

Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, by Drug (Acetaminophen, COX-2 inhibitors, Opioids, Non-steroidal Anti-inflammatories, Ketamine, and Others ), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Apr 2022
Code : CMI4998
Pages :177
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Key players operating in the market are focusing on the development and approval of novel therapeutics for the treatment of knee surgeries and arthroplasty pain, which is expected to offer a lucrative opportunity for market players to launch innovative products in the market

Key Players

Major players operating in the global knee surgeries and arthroplasty pain management therapeutics market include Pfizer Inc, Allay Therapeutics, Mallinckrodt, Johnson & Johnson, Zydus Cadila Healthcare Ltd., Novartis AG, Purdue Pharma, Delphis Pharmaceutical, Taj Pharmaceuticals Limited, GlaxoSmithKline plc, AbbVie Inc., and Aurobindo Pharma

Companies covered:

Pfizer Inc, Allay Therapeutics, Mallinckrodt, Johnson & Johnson, Zydus Cadila Healthcare Ltd., Novartis AG, Purdue Pharma, Delphis Pharmaceutical, Taj Pharmaceuticals Limited, GlaxoSmithKline plc, AbbVie Inc., and Aurobindo Pharma

KNEE SURGERIES AND ARTHROPLASTY PAIN MANAGEMENT THERAPEUTICS MARKET ANALYSIS

Leading Companies

Knee Surgeries And Arthroplasty Pain Management Therapeutics Market Report Snapshots

EXISTING CLIENTELE